65 results
424B4
RSLS
ReShape Lifesciences Inc.
3 Oct 23
Prospectus supplement with pricing info
9:23am
-Band device and pregnancy and another letter requesting additional information about a post on social media alleging death of a Lap-Band patient … communication with the FDA on this subject. Further investigation of the social media complaint that prompted the FDA request revealed that, the serious
8-K
EX-10.1
RSLS
ReShape Lifesciences Inc.
22 Sep 23
ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System
4:02pm
and social media, either directly or through third party distribution partners, which license shall be exclusive even as to LICENSOR, and
(b) the right … .
g. Approvals. All Licensor brand guidelines related to advertising and promotional materials, including but not limited to, the contents of social
8-K
EX-99.1
qy6jnwfva
15 Aug 22
ReShape Lifesciences™ Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:07pm
8-K
EX-99.1
2gayja0
23 May 22
ReShape Lifesciences™ Reports First Quarter 2022 Financial Results and Provides Corporate Update
10:33am
8-K
EX-99.1
uzkdeap5
28 Mar 22
ReShape Lifesciences™ Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update
5:30pm
425
dhagy p4alyw8wkn0
18 May 21
Business combination disclosure
9:28am
424B3
6tyzma5h75uvx8wu
13 Apr 21
Prospectus supplement
4:22pm
S-4/A
4ntr5tbcinfsf4u cxf
9 Apr 21
Registration of securities issued in business combination transactions (amended)
5:20pm
S-4
EX-10.38
pj5scy5itubapr
30 Mar 21
Registration of securities issued in business combination transactions
12:00am